NCT00872651View on ClinicalTrials.gov

Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 0.004%/Timolol 0.5%

Travoprost 0.004%/Timolol 0.5%

DRUG

Latanoprost 0.005% / Timolol 0.5%

Latanoprost 0.005% / Timolol 0.5%

Trial Locations (1)

510060

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00872651 - Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter